Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation

Journal of Cellular Biochemistry

Volumn 88, Issue 5, 2003, Pages 873-884

  Gerstenfeld, Louis C ^a   Cullinane, Dennis M ^a   Barnes, George L ^a   Graves, Dana T ^a   Einhorn, Thomas A ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; BMP; Fracture healing; Inflammatory cytokines

Indexed keywords

ANGIOGENIC FACTOR; CYTOKINE; METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE DEVELOPMENT; BONE GROWTH; BONE MARROW CELL; BONE MASS; BONE REMODELING; CALLUS; CELL DIFFERENTIATION; EMBRYO DEVELOPMENT; FRACTURE HEALING; GENETIC ASSOCIATION; HUMAN; MORPHOGENESIS; NONHUMAN; OSSIFICATION; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BIRTH INJURIES; BONE AND BONES; BONE REMODELING; BONY CALLUS; CYTOKINES; FRACTURE HEALING; GROWTH PLATE; HUMANS; INFANT, NEWBORN; METALLOPROTEASES; OSTEOGENESIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0037376627     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10435     Document Type: Article

References (66)

1. Barnes GL, Kostenuick PJ, Gerstenfeld LC, Einhorn TA. 1999. Growth factor regulation of fracture repair. J Bone Miner Res 14:1805-1815.
2. Barreto C, Wilsman NJ. 1994. Hypertrophic chondrocyte volume and growth rates in avian growth plates. Res Vet Sci 56:53-61.
3. Beamer WG, Shultz KL, Churchill GA, Frankel WN, Baylink DJ, Rosen CJ, Donahue LR. 1999. Quantitative trait loci for bone density in C57BL/6J and CAST/EiJ inbred mice. Mamm Genome 11:1043-1049.
4. Beamer WG, Shultz KL, Donahue LR, Churchill GA, Sen S, Wergedal JR, Baylink DJ, Rosen CJ. 2001. Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. J Bone Miner Res 16:1195-1206.
5. Bianco P, Riminucci M, Gronthos S, Robey PG. 2001. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19:180-192.
6. Bostrom MP, Lane JM, Berberian WS, Missri AA, Tomin E, Weiland A, Doty SB, Glaser D, Rosen VM. 1995. Immunolocalization and expression of bone morphogenetic protein 2 and 4 in fracture healing. J Ortho Res 13:357-367.
7. Bouletreau PJ, Warren SM, Spector JA, Peled ZM, Gerrets RP, Greenwald JA, Longaker MT. 2002. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: Implications for fracture healing. Plast Reconstr Surg 109:2384-2397.
8. Boyden LM, Mao J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP. 2002. High-bone density due to a mutation in the LDL-receptor related protein-5. N Eng J Med 346:1513-1521.
9. Breur GJ, VanEnkevort BA, Farnum CE, Wilsman NJ. 1991. Linear relationship between the volume of hypertrophic chondrocytes and the rate of longitudinal bone growth in growth plates. J Orthop Res 9:348-359.
10. Brunet LJ, McMahon JA, McMahon AP, Harland RM. 1998. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280(5368): 1455-1457.
11. Buckwalter JA, Einhorn TA, Marsh LJ. 2001. Bone and joint healing. In: Bucholz RW, Heckman JD, editors. Rockwood and Green's fractures in adults. Fifth edition. Philadelphia: Lippincott Williams & Wilkins. pp 245-271.
12. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM. 1990. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Nat Acad Sci USA 87:9843-9847.
13. Chang C, Hemmati-Brivanlou A. 1998. Xenopus GDF6, a new antagonist of Noggin and a partner of BMPs. Development 126:3347-3357.
14. Cho T-J, Gerstenfeld LC, Einhorn TA. 2002. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17:513-520.
15. Constantinides PG, Taylor SM, Jones PA. 1978. Phenotypic conversion of cultured mouse embryo cells by aza pyrimidine nucleosides. Dev Biol 66:57-71.
16. Cullinane DM, Fredrick A, Eisenberg SR, Pacicca D, Elman MV, Lee C, Salisbury K, Gerstenfeld LC, Einhorn TA. 2002. Induction of a neoarthrosis by precisely controlled motion in an experimental mid-femoral defect. J Orthop Res 20:579-586.
17. Deckers MM, van Bezooijen RL, van der Horst G, Hoogendam J, van Der Bent C, Papapoulos SE, Lowik CW. 2002. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143:1545-1553.
18. Einhorn T, Lee C. 2001. Bone regeneration: New findings and potential clinical applications. J Am Acad Orthp Surg 9:157-165.
19. Einhorn TA, Majeska RJ, Rush EB, Levine PM, Horowitz MC. 1995. The expression of cytokine activity by fracture callus. J Bone Miner Res 10:1272-1281.
20. Ferguson C, Alpern E, Miclau T, Helms JA. 1999. Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 87:57-66.
21. Ferrara N, Davis-Smyth T. 1997. The biology of vascular endothelial growth factor. Endocrin Rev 18:4-25.
22. Gerber H, Ferrara N. 2000. Angiogenesis and bone growth. Trends Cardiovasc Med 10:223-228.
23. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623-628.
24. Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Cruceta J, Graves D, Einhorn TA. 2001. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 169:285-294.
25. Gerstenfeld LC, Cruceta J, Shea CM, Sampath K, Barnes GL, Einhorn TA. 2002. Chondrocytes provide morphogenic signals that selectively induce osteogenic differentiation of mesenchymal stem cells. J Bone Miner Res 17:221-230.
26. Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn TA. 2003. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res (in press).
27. Glowacki J. 1998. Angiogenesis in fracture repair. Clin Orthop 355(Suppl):S82-9. (Review).
28. Goad D, Rubin J, Wang H. 1996. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and in murine osteoblasts induced by insulin-like growth factor I. Endocrin 137:2262-2268.
29. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG. 1993. An interleukin 1-like factor stimulates bone resorption in vitro. Nature 306:378.
30. Gu W, Li X, Lau KH, Edderkaoui B, Donahae LR, Rosen CJ, Beamer WG, Shultz KL, Srivastava A, Mohan S, Baylink DJ. 2002. Gene expression between a congenic strain that contains a quantitative trait locus of high bone density from CAST/EiJ and its wild-type strain C57BL/6J. Funct Integr Genomics 6:375-386.
31. Hadjiargyrou M, Lombardo F, Zhao S, Ahrens W, Joo J, Ahn H, Jurman M, White DW, Rubin CT. 2002. Transcriptional profiling of bone regeneration: Insight into the molecular complexity of wound repair. J Biol Chem 277:30177-30182.
32. Harada S, Rodan S, Rodan G. 1995. Expression and regulation of vascular endothelial growth factor in osteoblasts. Clin Orthop 313:76-80.
33. Harper J, Gerstenfeld LC, Klagsbrun M. 2001. Neuropilin-1 expression in osteogenic cells: Down-regulation during differentiation of osteoblasts into osteocytes. J Cell Biochem 81:82-92.
34. Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Marcus R, Matkovic V, Weaver C. 2001. Peak bone mass. Osteoporos Int 12:985-1009.
35. Hunziker EB, Schenk RK. 1989. Physiological mechanisms adopted by chondrocytes in regulating longitudinal bone growth in rats. J Physiol 414:55-71.
36. Iwata H, Sakano S, Itoh T, Bauer TW. 2002. Demineralized bone matrix and native bone morphogenetic protein in orthopaedic surgery. Clin Orthop 395:99-109.
37. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. 1997. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312.
38. Jingushi S, Urabe K, Okazaki K, Hirata G, Sakai A, Ikenoue T, Iwamoto Y. 2002. Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with beta-tricalcium phosphate as a carrier: In vivo bone banking for muscle-pedicle autograft. J Orthop Sci 7:490-494.
39. Joyce ME, Jinguishi S, Bolander ME. 1990. Transforming growth factor-β in the regulation of fracture repair. Ortho Clin North Am 21:199-220.
40. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755-1766.
41. Kim N, Odgren PR, Kim DK, Marks SC, Jr, Choi Y. 2000. Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc Natl Acad Sci USA 97:10905-10910.
42. Kimble RB, Vannice JL, Bloedow DC, Thompson RC, Hopfer W, Kung VT, Brownfield C, Pacifici R. 1994. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovarietomized rats. J Clin Invest 93:1959-1967.
43. Kimble RB, Bain S, Pacifici R. 1997. The functional block of TNF but not IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12:935-941.
44. Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA. 2001. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16: 1004-10014.
45. Le AX, Miclau T, Hu D, Helms JA. 2001. Molecular aspects of healing in stabilized and non-stabilized fractures. J Orthop Res 19:78-84.
46. Lehmann W, Edgar CM, Cho T-J, Tsay A, Amling M, Rueger JM, Gerstenfeld LC, Einhorn TA. 2002. Temporal expression of meatalloproteinases and angiogenic factors during murine fracture healing and their dependence on TNF-Alpha. J Bone Min Res 17:S227.
47. Li X, Gu W, Masinde G, Hamilton-Ulland M, Xu S, Mohan S, Baylink DJ. 2001a. Genetic control of the rate of wound healing in mice. Heredity 86:668-674.
48. Li X, Gu W, Masinde G, Hamilton-Ulland M, Rundle CH, Mohan S, Baylink DJ. 2001b. Genetic variation in bone-regenerative capacity among inbred strains of mice. Bone 29:134-140.
49. Masinde GL, Li X, Gu W, Davidson H, Mohan S, Baylink DJ. 2001. Identification of wound healing/regeneration quantitative trait loci (QTL) at multiple time points that explain seventy percent of variance in (MRL/MpJ and SJL/J) mice F2 population. Genome Res 11:2027-2033.
50. Nakahara H, Bruder SP, Haynesworth SE, Holecek JJ, Baber MA, Goldberg VM, Caplan AI. 1990. Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. Bone 11:181-188.
51. Nakase T, Nomura S, Yoshikawa H, Hashimoto J, Hirota S, Kitamura Y, Oikawa S, Ono K, Takaoka K. 1994. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 5:651-659.
52. Reddi AH. 2001a. Bone morphogenetic proteins: from basic science to clinical applications. J Bone Joint Surg 83A:S1, 1-6.
53. Reddi AH. 2001b. Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: Noggin, chordin and DAN. Arthritis Res 3:1-5.
54. Richman C, Kutilek S, Miyakoshi N, Srivastava AK, Beamer WG, Donahue LR, Rosen CJ, Wergedal JE, Baylink DJ, Mohan S. 2001. Postnatal and pubertal skeletal changes contribute predominantly to the differences in peak bone density between C3H/HeJ and C57BL/6J mice. J Bone Miner Res 16:386-397.
55. Rosier RN, O'Keefe RJ, Hicks DG. 1998. The potential role of transforming growth factor-beta in fracture healing. Clin Orthop Rel Res 355S:294-300.
56. Rowe NM, Mehara BJ, Luchs JS, Dudziak ME, Steinbrech DS, Illei PB, Fernadez GJ, Gittes GK, Longaker MT. 1999. Angiogenesis during mandibular distraction osteogenesis. Ann Plast Surg 42:470-475.
57. Sekiya I, Vuoristo JT, Larson BL, Prockop DJ. 2002. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci USA 99:4397-4402.
58. Street J, Bao M, deGuzman L, Bunting S, Peale FV, Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH. 2002. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99:9656-9661.
59. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
60. Urist MR. 1965. Bone: Formation by autoinduction. Science 150:893-899.
61. Vortkamp A, Pathi S, Peretti GM, Caruso EM, Zaleske DJ, Tabin CJ. 1998. Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair. Mech Dev 71:65-76.
62. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411-422.
63. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. 1988. Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534.
64. Yeh LC, Lee JC. 1999. Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells. Mol Cell Endocrinol 153:113-124.
65. Yoshimura Y, Nomura S, Kawasaki S, Tsutsumimoto T, Shimizu T, Takaoka K. 2001. Co-localization of noggin and bone morphogenetic protein-4 during fracture healing. J Bone Miner Res 16:876-884.
66. Zelzer E, Glotzer DJ, Hartmann C, Thomas D, Fukai N, Soker S, Olsen BR. 2001. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 106:97-106.